Skip to main content
Table of Contents
Print

How Does Cannabis Compare to Anticonvulsants in Treating CRPS? 

Author: Dr. Clarissa Morton, PharmD

Anticonvulsants like gabapentin and pregabalin are commonly prescribed for Complex Regional Pain Syndrome. They’re designed to reduce hyperactive nerve signals, but side effects like sedation, weight gain, or dizziness can make long-term use difficult. This has led many patients to explore how cannabis vs anticonvulsants compares as a strategy for relief. 

Cannabis, once sidelined in mainstream medicine, is now emerging as one of the more promising alternative therapies for chronic nerve conditions, including CRPS. 

Breaking Down the Comparison 

Here’s how cannabis vs anticonvulsants looks when evaluating their roles in CRPS care: 

  • Mechanism of action 
    Anticonvulsants target calcium channels in the nervous system to reduce pain signalling. Cannabis, on the other hand, works through the endocannabinoid system, modulating inflammation, mood, and pain response in a more holistic manner. Both are non-opioid therapies, but they work in distinct ways. 
  • Side-effect profile 
    While neither is completely side-effect-free, many patients report fewer cognitive issues and less fatigue on cannabis compared to traditional nerve medications. That said, THC must still be managed carefully to avoid unwanted psychoactive effects. 
  • Efficacy and flexibility 
    Anticonvulsants often take weeks to show results and may not help everyone. Cannabis allows more flexible dose adjustment and formats, such as oils, capsules, and vapourisers, which can support personalisation and quicker chronic pain relief. 
  • Complementary potential 
    Rather than an either/or decision, many patients use cannabis to supplement lower doses of anticonvulsants, especially when tapering or facing side-effect burdens. 

The cannabis vs anticonvulsants conversation ultimately comes down to how your body responds and what side effects you’re willing to manage for relief. 

Visit providers like LeafEase to explore safe, guided options for integrating cannabis into your CRPS treatment plan. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS).

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories